Behavioural screen in C. elegans reveals Parkinson’s drug candidates
Researchers have developed a workflow to study the behaviour of C. elegans in a high-throughput screen to identify Parkinson's disease drugs.
List view / Grid view
Researchers have developed a workflow to study the behaviour of C. elegans in a high-throughput screen to identify Parkinson's disease drugs.
Between January and October 2020, scientists globally have published more than 87,000 papers about the coronavirus.
Scientists have developed a compound that stops the degeneration of upper motor neurons, a contributor to amyotrophic lateral sclerosis (ALS).
Researchers have shown that a guide RNA can be used in CRISPR gene editing to ensure sequential Cas9 cuts to DNA.
Vascor (bepridil) could be used to treat COVID-19, according to a new study which screened drugs to repurpose against SARS-CoV-2.
Researchers have found that the S1/S2 cleavage of the SARS-CoV-2 Spike protein could be a potential target for COVID-19 therapeutics.
A monoclonal antibody given to mice reversed type 1 diabetes by suppressing the actions of glucagon, a study has shown.
A high-throughput screening assay for macrocyclic peptides with affinity to ubiquitin has been created by researchers.
Researchers have developed a computer modelling programme that can produce genetic circuits for cellular engineering.
Using liquid chromatography/mass spectrometry, researchers have revealed no major differences in glycan structures in two prion strains.
Research has shown that MAPK4 activates two molecules in cellular signalling pathways involved in prostate cancer growth.
A version of the FOXO3 gene can protect brain stem cells from stress during ageing, according to a new study.
The UK Government will give £18.5 million in funding to four studies researching the causes and potential treatments of long COVID.
Researchers have shown that adding a polymer to glutamate-oxaloacetate transaminase means the molecule can treat stroke for up to six days in rats.
For the first time, scientists have grown bile duct organoids that could repair damaged ducts and livers as a new cell therapy.